Pharma merger forms $6B company

Eversana, a pharmaceutical distributor and marketing company, has acquired a software company with plans to disrupt “the industry’s misaligned incentives and fragmented patient experiences,” according to an Aug. 26 news release. 

The acquired firm, Waltz Health, offers prescription drug-pricing technology to health plans and employers. The software compares prescription savings programs, and it processes about 250 million prescriptions annually, Bloomberg reported Aug. 26. 

The combined organization is valued at $6 billion, according to the report. 

Mark Thierer, CEO and co-founder of Waltz Health and chair of Eversana, will lead the combined company. Mr. Thierer previously served as CEO of Optum Rx, a pharmacy benefit manager and part of UnitedHealth Group. 

The post Pharma merger forms $6B company appeared first on Becker’s Hospital Review | Healthcare News & Analysis.